A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback